U.S. RESEARCH ROUNDUP-Adobe, Oracle, Zscaler June 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Oracle Corp and Zscaler, on Friday. HIGHLIGHTS * Adobe Inc ADBE.O : Baird raises target price to $545 from $525 * Bandwidth Inc BAND.O : Morgan Stanley cuts to underweight from equal-weight * Corpay Inc CPAY.N : Jefferies cuts target price to $295 from $330 * Oracle Corp ORCL.N : Berenberg raises target price t

BRIEF-Becton, Dickinson And Co Files For Offering Of $600 Million 5.081% Notes Due 2029 - SEC Filing June 4 (Reuters) - Becton Dickinson and Co BDX.N : BECTON, DICKINSON AND CO FILES FOR OFFERING OF $600 MILLION 5.081% NOTES DUE 2029 - SEC FILING Source text for Eikon: [ID:n0001140361-24-028860] Further company coverage: BDX.N

BRIEF-Becton Dickinson Euro Finance S.À R.L Files For Offering Of €800 Million 4.029% Notes Due 2036 - SEC Filing June 4 (Reuters) - Becton Dickinson and Co BDX.N : BECTON DICKINSON EURO FINANCE S.À R.L FILES FOR OFFERING OF €800 MILLION 4.029% NOTES DUE 2036 - SEC FILING Source text for Eikon: [ID:n0001140361-24-028859] Further company cover

BRIEF-Becton, Dickinson And Company Files For Offering Of €1 Billion 3.828% Notes Due 2032 -SEC Filing June 4 (Reuters) - Becton Dickinson and Co BDX.N : BECTON, DICKINSON AND COMPANY FILES FOR OFFERING OF €1 BILLION 3.828% NOTES DUE 2032 -SEC FILING Source text for Eikon: [ID:n0001140361-24-028858] Further company coverage: BDX.N

Deals of the day-Mergers and acquisitions Adds Paramount Global, Deutsche Telekom June 3 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday: ** Skydance Media was awaiting a response to its enhanced bid for entertainment conglomerate Paramount Global PARA.O , in which it offered to buy nearly half of the nonvoting Paramount shares at $15 each, according to a source familiar with the matter.

BUZZ-U.S. STOCKS ON THE MOVE-Arrowhead, Novavax, Precigen Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 inched up on Monday as falling U.S. Treasury yields boosted megacap growth stocks, while investors assessed data that showed local manufacturing activity had eased for the second consecutive month in May.

Deals of the day-Mergers and acquisitions Adds: Stericycle, Edwards Lifesciences, Pershing Square Capital Management, LexisNexis, STC Group Updates: Waste Management June 3 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday: ** Waste Management said it will take Stericycle SRCL.O private in a deal valued at $7.2 billion, as it looks to tap into the growing healthcare waste disposal market in the United States.

BUZZ-Edwards Lifesciences rises; to sell critical care unit for $4.2 bln ** Shares of medical device maker Edwards Lifesciences EW.N rise 3.4% to $89.80 premarket ** Says it has agreed to sell its critical care products unit to Becton Dickinson BDX.N in an all-cash transaction valued at $4.2 billion ** With this agreement, co is no longer pursuing

UPDATE 3-Edwards to sell critical care products unit to Becton Dickinson for $4.2 bln Adds analyst comment in paragraph 3 and background paragraph 4 onwards By Pratik Jain June 3 (Reuters) - Edwards Lifesciences EW.N on Monday said it has agreed to sell its critical care products unit to Becton Dickinson BDX.N in an all-cash deal valued at $4.2 billion to sharpen focus on its heart devices business.

BRIEF-Edwards Lifesciences To Sell Critical Care To BD June 3 (Reuters) - Edwards Lifesciences Corp EW.N : EDWARDS LIFESCIENCES TO SELL CRITICAL CARE TO BD EDWARDS LIFESCIENCES SELLS CRITICAL CARE TO BD FOR $4.2 BILLION EDWARDS LIFESCIENCES CORP - PROPOSED DEAL FOR $4.2 BILLION EDWARDS TO FUND STRATEGIC GROWTH INVESTMENTS FROM SALE PROCEEDS EDWARDS

Edwards Lifesciences to sell its critical products unit to Becton Dickinson for $4.2 bln June 3 (Reuters) - Edwards Lifesciences EW.N on Monday said it has agreed to sell its critical care products unit to Becton, Dickinson and Co BDX.N in an all-cash transaction valued at $4.2 billion. Reporting by Pratik Jain in Bengaluru; Editing by Tasim Zahid

BRIEF-BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Bln June 3 (Reuters) - BD and Edwards Lifesciences: BD TO ACQUIRE EDWARDS LIFESCIENCES' CRITICAL CARE PRODUCT GROUP FOR $4.2 BILLION TO EXPAND SMART CONNECTED CARE SOLUTIONS AND BECOME AN ADVANCED MONITORING TECHNOLOGY LEADER BD: EXPECTS TO FUND ALL-CASH TRANSACTION WITH

U.S. RESEARCH ROUNDUP-Connectone Bancorp, Hormel Foods, UMB Financial May 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Connectone Bancorp, Hormel Foods and UMB Financial, on Friday. HIGHLIGHTS * Connectone Bancorp Inc CNOB.O : KBW cuts to market perform from outperform * Hancock Whitney Corp HWC.O : KBW raises to outperform from market perform * Hormel Foods Corp HRL.N : JP Morgan raises to neutral from underwe

EXCLUSIVE-Biden to put tariffs on China medical supplies - sources By Jarrett Renshaw and Trevor Hunnicutt May 10 (Reuters) - The Biden administration is expected to issue new tariffs on Chinese-made medical devices like syringes and personal protective equipment when it unveils its new trade strategy next week, according to two sources familiar with the decision.

U.S. RESEARCH ROUNDUP- Paramount Global, Sprout Social, Williams-Sonoma May 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Paramount Global, Sprout Social and Williams-Sonoma ,on Friday. HIGHLIGHTS * Expedia Group Inc EXPE.O : Piper Sandler cuts to neutral from overweight * Paramount Global PARA.O : Seaport Research Partners cuts to neutral from buy * Sprout Social Inc SPT.O : Piper Sandler cuts to neutral from ov

BUZZ-U.S. STOCKS ON THE MOVE-Sarepta, Zoetis, Pioneer Natural Resources Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes advanced on Thursday, a day after the Federal Reserve left interest rates unchanged and signaled a dovish tilt, with focus moving to a crucial job report later in the week.

BUZZ-U.S. STOCKS ON THE MOVE-Becton, Sarepta, Zoetis Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes advanced on Thursday, a day after the Federal Reserve left interest rates unchanged and allayed worries around potential rate hikes, with focus moving to a crucial job report later in the week.

BUZZ-Becton climbs on 2024 profit forecast raise ** Shares of medical device maker Becton Dickinson BDX.N rise ~3.2% to $241.09 ** Co raises its annual profit forecast to $12.95 to $13.15 per share, up from its previous forecast of $12.82 to $13.06 per share ** "Longer term, we remain optimistic on the outlook for BD as the company appears to be well on its way to achieving its BD 2025 commitments" - William Blair analyst Andrew Brackmann ** Co reports Q2 adj.

Becton Dickinson and Co reports results for the quarter ended in March - Earnings Summary Becton Dickinson and Co BDX.N reported quarterly adjusted earnings of $3.17​​ per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of $2.86. The mean expectation of thirteen analysts for the quarter was for earnings of $2.97 per share.

Becton Dickinson lifts profit view on strong surgical equipment demand May 2 (Reuters) - Becton Dickinson BDX.N raised its annual profit forecast and beat second-quarter profit estimates on Thursday, as the group banks on strong demand for its surgical equipment and syringes. Medical technology firms like Becton, Boston Scientific BSX.N and Abbott Laboratories ABT.N are benefiting from a boost in demand as more people, especially older patients, undergo surgeries that were put on hold during the